We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
James Bussel MD

James B. Bussel MD

Emeritus Professor of Pediatrics, Medicine and Obstetrics and Gynecology at Weill Cornell Medicine, New York, New York

Dr James Bussel is Emeritus Professor of Pediatrics, Medicine and Obstetrics and Gynecology at Weill Cornell Medicine in New York City.   He graduated cum laude from Yale University, attended Medical school at Columbia College of Physicians and Surgeons, did his residency in Pediatrics at Cincinnati Children’s Hospital, and a fellowship in Pediatric Hematology-Oncology at Weill Cornell and Memorial Sloan Kettering. Since 1981 he has been an attending at New York Presbyterian Hospital and a professor at Weill Cornell Medicine.  His clinical and clinical research interests have been largely in Immune ThrombocytoPenia (ITP) and Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT).  He has published over 400 manuscripts predominantly in these areas. Six are first or second authored in the New England Journal of Medicine. In 2012 with Dr Richard Berkowitz he shared the King Faisal International Prize for Medicine (the so-called Arab Nobel Prize) for their  work in non-invasive management of FNAIT. Dr Bussel has participated in the first ASH ITP guideline development and in the Consensus manuscript. He has been a reviewer for multiple journals, an ad hoc reviewer for the NIH, and an abstract reviewer for ASH and EHA. His wife’s family is from England.


Dr. Bussel reports the following disclosures:
  • Ad boards: Novartis, Amgen, Shionogi, Rigel, Momenta
  • Honoraria: Up to Date
  • Clinical research: Novartis, Amgen, Rigel
  • Consultant: Novartis, Rigel
  • no equity